The National Institutes of Health has published new guidance on disclosure of outside activities, related to the prevention of inapprorpate foreign inluence.  This information, including useful tables, can be found at NIH's "Protecting U.S. Biomedical Intellectual Innovation" webpage.

The U.S. government has growing concerns about inappropriate influence by foreign governments over federally funded research. In August 2018, the NIH Director issued a statement about incidents that violate core principles and threaten the integrity and academic competitiveness of U.S. biomedical research and innovation, including:

• failure to disclose all conflicts of interest, foreign affiliations, conflicts of commitment, and other support in applications for NIH grants;
• diversion of proprietary or pre-publication information disclosed in grant applications or produced by NIH-supported research to those not authorized to receive it; and
• breaches of confidentiality in peer review.

NIH has taken a number of steps to address these risks, including convening a working group of the Advisory Committee to the Director (ACD) to deliberate on the matter and advise him on how best to address it. The ACD delivered a set of recommendations, many of which are being implemented by NIH.

Requirements for Disclosure of Other Support, Foreign Relationships and Activities, as well as Conflicts of Interest

Full transparency in NIH applications and throughout the life of an NIH grant is critical. NIH requires the disclosure of all research support, foreign components, and financial conflicts of interest (FCOI). NIH uses this information when making its funding decisions to determine if the research being proposed is receiving other sources of funding that could be duplicative, has the necessary time allocation and resources to conduct the research. 

Read more at: https://grants.nih.gov/policy/protecting-innovation.htm